BeOne Medicines (BEIGF) Asset Utilization Ratio (2016 - 2026)

BeOne Medicines (BEIGF) has reported Asset Utilization Ratio for 11 consecutive years, with 0.69 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio fell 8.01% year-over-year to 0.69 in Q2 2026; TTM through Jun 2026 was 0.69, a 8.01% decrease from a year earlier, with the FY2025 full-year figure at 0.76, up 16.54% from the prior year.
• Asset Utilization Ratio was 0.69 for Q2 2026 at BeOne Medicines, up from 0.69 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.75 in Q2 2025 and troughed at 0.11 in Q1 2022.
• A 5-year average of 0.47 and a median of 0.51 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio decreased 29.87% in 2022 and surged 138.29% in 2023, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.22 in 2022, then surged by 100.86% to 0.43 in 2023, then soared by 49.41% to 0.65 in 2024, then increased by 4.16% to 0.68 in 2025, then increased by 2.36% to 0.69 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.69 (Q2 2026), 0.69 (Q1 2026), and 0.68 (Q4 2025), per Business Quant data.